Cumulative effects of AT1 and AT2 receptor blockade on ischaemia-reperfusion recovery in rat hearts

被引:11
作者
Ryckwaert, F
Colson, P
Guillon, G
Foëx, P
机构
[1] INSERM, U469, F-34094 Montpellier, France
[2] Univ Oxford, Nuffield Dept Anaesthet, Oxford OX2 6HE, England
关键词
renin-angiotensin system; angiotensin II receptor antagonist; Langendorff; ischaemia/reperfusion; coronary flow;
D O I
10.1016/j.phrs.2004.12.003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Though ischaemia/reperfusion injury induces renin-angiotensin systemic (RAS) activation and increased heart angiotensin production, the effects of blockade of the two main angiotensin 11 receptors, AT, and AT2, are not definitively established. Using a Langendorff heart preparation, effects of Valsartan 10' M (AT, receptor blocker), PD 123319 10-7 M (AT2 receptor blocker) or both in the presence of a controlled concentration of angiotensin 11 (10-8 M) in order to reproduce systemic RAS activation were studied in adult male Wistar rat heartssubmitted to ischaemia/reperfusion. Ischaemia/reperfusion impaired both systolic and diastolic function through a no-reflow phenomenon. Presence of a controlled concentration of angiotensin in the perfusate, enough to produce a significant AT, -induced vasoconstriction before ischaernia, has no relevant influence on ischaemia/reperfusion injury. Only blockade of both AT, and AT2 receptors significantly improved recovery from ischaemia; better ventricle function paralleled better perfusion. The results suggest that blockade of angiotensin 11 receptors is cumulative since blockade of AT, and AT2 receptors is more effective than blockade of just one of them. 0 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:497 / 502
页数:6
相关论文
共 20 条
[1]   Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide [J].
Brosnihan, KB ;
Li, P ;
Ferrario, CM .
HYPERTENSION, 1996, 27 (03) :523-528
[2]   Localization and production of angiotensin II in the isolated perfused rat heart [J].
de Lannoy, LM ;
Danser, AHJ ;
Bouhuizen, AMB ;
Saxena, PR ;
Schalekamp, MADH .
HYPERTENSION, 1998, 31 (05) :1111-1117
[3]   Angiotensin II and the heart - On the intracrine renin-angiotensin system [J].
De Mello, WC ;
Danser, AHJ .
HYPERTENSION, 2000, 35 (06) :1183-1188
[4]   The cardiac renin-angiotensin system - Conceptual, or a regulator of cardiac function? [J].
Dostal, DE ;
Baker, KM .
CIRCULATION RESEARCH, 1999, 85 (07) :643-650
[5]   The coronary no-reflow phenomenon: a review of mechanisms and therapies [J].
Eeckhout, E ;
Kern, MJ .
EUROPEAN HEART JOURNAL, 2001, 22 (09) :729-739
[6]   LIMITATION OF EXPERIMENTAL INFARCT SIZE BY AN ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR [J].
ERTL, G ;
KLONER, RA ;
ALEXANDER, RW ;
BRAUNWALD, E .
CIRCULATION, 1982, 65 (01) :40-48
[7]   Opposite effects of angiotensin AT(1) and AT(2) receptor antagonists on recovery of mechanical function after ischemia-reperfusion in isolated working rat hearts [J].
Ford, WR ;
Clanachan, AS ;
Jugdutt, BI .
CIRCULATION, 1996, 94 (12) :3087-3089
[8]   Angiotensin-(1-7) attenuates the development of heart failure after myocardial infarction in rats [J].
Loot, AE ;
Roks, AJM ;
Henning, RH ;
Tio, RA ;
Suurmeijer, AJH ;
Boomsma, F ;
van Gilst, WH .
CIRCULATION, 2002, 105 (13) :1548-1550
[9]   Metabolism of angiotensin I in the coronary circulation of normal and diabetic rats [J].
Mahmood, A ;
Jackman, HL ;
Teplitz, L ;
Igic, R .
PEPTIDES, 2002, 23 (06) :1171-1175
[10]   SEPARATION OF RATE OF LEFT-VENTRICULAR RELAXATION FROM CHAMBER STIFFNESS IN RATS [J].
MOMOMURA, S ;
IIZUKA, M ;
SERIZAWA, T ;
SUGIMOTO, T .
AMERICAN JOURNAL OF PHYSIOLOGY, 1988, 255 (06) :H1468-H1475